These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 8896065)
1. Secretion of parathyroid hormone-related peptide in patients with multiple myeloma. Beaudreuil J; Cohen-Solal M; Doré MX; Vernejoul MC; Bardin T; Celton N; Giraudeaux V; Kuntz D Rev Rhum Engl Ed; 1996; 63(7-8):502-3. PubMed ID: 8896065 [TBL] [Abstract][Full Text] [Related]
2. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma. Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119 [TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein mRNA and protein expression in multiple myeloma: a case report. Schneider HG; Kartsogiannis V; Zhou H; Chou ST; Martin TJ; Grill V J Bone Miner Res; 1998 Oct; 13(10):1640-3. PubMed ID: 9783553 [TBL] [Abstract][Full Text] [Related]
4. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia. Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289 [TBL] [Abstract][Full Text] [Related]
5. Megakaryoblastic transformation of polycythemia vera with hypercalcemia. Kurosawa M; Iwasaki H Ann Hematol; 2002 Nov; 81(11):668-71. PubMed ID: 12454709 [TBL] [Abstract][Full Text] [Related]
6. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357 [TBL] [Abstract][Full Text] [Related]
7. [High PTHrP level induced hypercalcemia and acute renal failure in a multiple myeloma patient]. Saito O; Kurosu M; Ando Y; Kusano E; Asano Y Nihon Jinzo Gakkai Shi; 2000 Jan; 42(1):41-6. PubMed ID: 10737013 [TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide. Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119 [TBL] [Abstract][Full Text] [Related]
9. Lymphoma with hypercalcemia. Walker IR Can Med Assoc J; 1974 Nov; 111(9):928-30. PubMed ID: 4608255 [TBL] [Abstract][Full Text] [Related]
10. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient. Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480 [TBL] [Abstract][Full Text] [Related]
11. [Hypercalcemia in myeloma]. Abe M Nihon Rinsho; 2007 Dec; 65(12):2245-9. PubMed ID: 18069268 [TBL] [Abstract][Full Text] [Related]
13. Assessment of cellular expression of parathyroid hormone-related protein mRNA and protein in multiple myeloma. Zeimer H; Firkin F; Grill V; Slavin J; Zhou H; Martin TJ J Pathol; 2000 Nov; 192(3):336-41. PubMed ID: 11054717 [TBL] [Abstract][Full Text] [Related]
14. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy. Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601 [TBL] [Abstract][Full Text] [Related]
15. A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Body JJ; Greipp P; Coleman RE; Facon T; Geurs F; Fermand JP; Harousseau JL; Lipton A; Mariette X; Williams CD; Nakanishi A; Holloway D; Martin SW; Dunstan CR; Bekker PJ Cancer; 2003 Feb; 97(3 Suppl):887-92. PubMed ID: 12548591 [TBL] [Abstract][Full Text] [Related]
16. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy. Reagan P; Pani A; Rosner MH Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907 [TBL] [Abstract][Full Text] [Related]
17. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. Chattopadhyay N Am J Physiol Endocrinol Metab; 2006 May; 290(5):E761-70. PubMed ID: 16603723 [TBL] [Abstract][Full Text] [Related]
18. A case of myeloma with hypercalcemia caused by high serum concentrations of both parathyroid hormone-related peptide (PTHrP) and macrophage inflammatory protein-1α (MIP-1α). Shimizu H; Monden T; Tomotsune T; Nakatani Y; Domeki N; Matsumura M; Jojima T; Kawagoe Y; Kasai K Intern Med; 2011; 50(24):2993-6. PubMed ID: 22185991 [TBL] [Abstract][Full Text] [Related]